Mechanisms and management of nausea and emesis associated with cancer therapyDICATO, M.Oncology. 1996, Vol 53, pp 1-110, issn 0030-2414, SUP1Conference Proceedings

Optimal control of cyclophosphamide-induced emesisSTEWART, A.Oncology. 1996, Vol 53, pp 32-38, issn 0030-2414, SUP1Conference Paper

Biosimilaires actuellement disponibles en hémato-oncologie Partie 1: ASEs (agents stimulant l'érythropoïèse) : Les Biosimilaires = Presently available biosimilars in hematology-oncology ― Part I: ESAs : BiosimilarsKAMIONER, D; DICATO, M.Oncologie (Paris). 2011, Vol 13, Num 5, pp 209-212, issn 1292-3818, 4 p.Article

Antiemetic study methodology : Recommendations for future studiesOLVER, I. N.Oncology. 1996, Vol 53, pp 96-101, issn 0030-2414, SUP1Conference Paper

The severity and pattern of emesis following different cytotoxic agentsMARTIN, M.Oncology. 1996, Vol 53, pp 26-31, issn 0030-2414, SUP1Conference Paper

Angiœdème du côlon = Angioneurotic edema of the colonDONDELINGER, R; DICATO, M.Radiologie (Berlin). 1984, Vol 4, Num 1, pp 37-38, issn 0720-3322Article

Facteurs de risque non génétiques dans le cancer du sein = Non genetic risk factors for breast cancerDICATO, M.Le Sein (Paris). 2003, Vol 13, Num 2, pp 68-69, issn 1163-1961, 2 p.Conference Paper

La chimioembolisation transcutanée de métastases hépatiques = Chemoembolization of liver metastasesRAUH, S; DICATO, M.Médecine et hygiène. 2000, Vol 58, Num 2302, pp 1173-1175, issn 0025-6749Article

Nouveaux anticoagulants: ont-ils déjà une place en oncologie ? : Thrombose et cancer = Novel anticoagulants: do they already have a place in oncology departments ? : Thrombosis and cancerDICATO, M; PLAWNY, L.Oncologie (Paris). 2012, Vol 14, Num 12, pp 659-662, issn 1292-3818, 4 p.Article

Management of cisplatin-induced delayed emesisHESKETH, P.Oncology. 1996, Vol 53, pp 73-77, issn 0030-2414, SUP1Conference Paper

Serotonin mechanisms in chemotherapy-induced emesis in cancer patientsCUBEDDU, L. X.Oncology. 1996, Vol 53, pp 18-25, issn 0030-2414, SUP1Conference Paper

Treatment of advanced and refractory breast cancer with doxorubicin, vincristine and continous infusion of verapamil. A phase I-II clinical trialRIES, F; DICATO, M.Medical oncology and tumor pharmacotherapy. 1991, Vol 8, Num 1, pp 39-43, issn 0736-0118, 5 p.Article

The regulation of gene expression and the molecular basis of cancerPAULY, M; DICATO, M.Biomedicine & pharmacotherapy. 1990, Vol 44, Num 4, pp 195-198, issn 0753-3322Article

Management of cyclophosphamide-induced emesis over repeat coursesSOUKOP, M.Oncology. 1996, Vol 53, pp 39-45, issn 0030-2414, SUP1Conference Paper

EVENTRATIONS DIAPHRAGMATIQUES DE LA COUPOLE DROITELAMESCH A; ZAPP E; SCHROELL M et al.1981; PEDIATRIE; ISSN 0031-4021; FRA; DA. 1981; VOL. 36; NO 5; PP. 393-398; ABS. ENG; BIBL. 14 REF.Article

Clinical and methodological issues in antiemetic therapy : a worldwide survey of experts' opinionsBALLATORI, E; ROILA, F; HESKETH, P et al.Supportive care in cancer. 1997, Vol 5, Num 4, pp 269-273, issn 0941-4355Article

Cisplatin and emesis : Aspects of treatment and a new trial for delayed emesis using oral dexamethasone plus ondansetron beginning at 16 hours after cisplatinGRALLA, R. J; RITTENBERG, C; PERALTA, M et al.Oncology. 1996, Vol 53, pp 86-91, issn 0030-2414, SUP1Conference Paper

Towards understanding the aetiology and pathophysiology of the emetic reflex : Novel approaches to antiemetic drugsBOUNTRA, C; GALE, J. D; GARDNER, C. J et al.Oncology. 1996, Vol 53, pp 102-110, issn 0030-2414, 8 p., SUP1Conference Paper

Control of acute cisplatin-induced emesis over repeat courses of chemotherapyROILA, F.Oncology. 1996, Vol 53, pp 65-72, issn 0030-2414, SUP1Conference Paper

Management of other non-cisplatin-induced emesisSCHMOLL, H.-J; CASPER, J.Oncology. 1996, Vol 53, pp 51-55, issn 0030-2414, SUP1Conference Paper

Mechanisms of chemotherapy/radiotherapy-induced emesis in animal modelsNAYLOR, R. J; RUDD, J. A.Oncology. 1996, Vol 53, pp 8-17, issn 0030-2414, SUP1Conference Paper

Management of minimal residual malignancy in manREIZENSTEIN, P; MATHE, G; DICATO, M et al.Medical oncology and tumor pharmacotherapy. 1988, issn 0736-0118, 102 p., suppl. no 1Serial Issue

Adjuvant treatment of colorectal cancer (current expert opinion derived from the Third International Conference: Perspectives in Colorectal Cancer, Dublin, 2001)VAN CUTSEM, E; DICATO, M; LABIANCA, R et al.European journal of cancer (1990). 2002, Vol 38, Num 11, pp 1429-1436, issn 0959-8049Article

Page / 3